Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Retained Earnings (2014 - 2026)

Ocugen's (OCGN) quarterly Retained Earnings came in at $429.5 million in Q1 2026, up 220.81% YoY from $133.9 million in Q1 2025, and up 704078.69% on a QoQ basis from $61000.0 in Q4 2025.

Analysis

Ocugen (OCGN) Retained Earnings (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Retained Earnings data on file, last reported at $429.5 million in Q1 2026.

  • Quarterly Retained Earnings rose 220.81% year-over-year to $429.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $429.5 million (up 220.81% YoY) and the FY2025 annual result came in at $61000.0, up 27.08% from the prior year.
  • Retained Earnings rose to $429.5 million in Q1 2026, from $61000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $429.5 million in Q1 2026 to a low of -$390.4 million in Q3 2025.
  • A 5-year average of -$122.4 million and a median of -$200.7 million in 2022 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2025 — Retained Earnings sank 1697491.3% — and 2026, when it soared 220.81%.
  • Tracing OCGN's Retained Earnings over 5 years: stood at -$223.1 million in 2022, then declined by 28.27% to -$286.2 million in 2023, then surged by 100.02% to $48000.0 in 2024, then gained by 27.08% to $61000.0 in 2025, then soared by 704078.69% to $429.5 million in 2026.
  • The last three Retained Earnings figures came in at $429.5 million (Q1 2026), $61000.0 (Q4 2025), and -$390.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Ocugen 458.91 Mn 358.81 Mn - -452.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -452.12 Mn
Mar 31, 2026 429.55 Mn
Dec 31, 2025 -408.07 Mn
Sep 30, 2025 390.76 Mn
Jun 30, 2025 370.47 Mn
Mar 31, 2025 368.57 Mn
Dec 31, 2024 366.94 Mn
Sep 30, 2024 364.09 Mn
Jun 30, 2024 327.74 Mn
Mar 31, 2024 325.80 Mn
Dec 31, 2023 324.19 Mn
Sep 30, 2023 322.45 Mn
Jun 30, 2023 320.18 Mn
Mar 31, 2023 303.07 Mn
Dec 31, 2022 294.87 Mn
Sep 30, 2022 284.23 Mn
Jun 30, 2022 281.14 Mn
Mar 31, 2022 278.70 Mn
Dec 31, 2021 225.54 Mn
Sep 30, 2021 222.25 Mn